Literature DB >> 16785571

Homozygosity for the IgG2 subclass allotype G2M(n) protects against severe infection in hereditary C2 deficiency.

Göran Jönsson1, Vivi-Anne Oxelius, Lennart Truedsson, Jean Henrik Braconier, Gunnar Sturfelt, Anders G Sjöholm.   

Abstract

Homozygous C2 deficiency (C2D) is the most common deficiency of the classical complement pathway in Western countries. It is mostly found in patients with autoimmune disease or susceptibility to bacterial infections and in healthy persons. We wished to assess to what extent other immunological factors might explain differences of susceptibility to infections in C2D. For this reason, 44 Swedish patients with C2D were stratified with regard to the severity of documented infections. Investigations of IgG subclass levels, IgG subclass-specific GM allotypes, concentrations of factor B, properdin, and factor H, and polymorphisms of mannan-binding lectin and the Fc receptors FcgammaRIIa and FcgammaRIIIb were performed. Homozygosity for the G2M*n allele, which is known to promote Ab responses to polysaccharide Ags, was strongly associated with the absence of severe infections (p < 0.001) in the patients, suggesting a major protective role. The combination of mannan (or mannose)-binding lectin and C2 deficiency was found to be a minor susceptibility factor for invasive infection (p = 0.03). Low concentrations of IgG2 and factor B might sometimes contribute to susceptibility to infection. Other factors investigated did not appear to be important. In conclusion, the findings indicated that efficient Ab responses to polysaccharides are protective against severe infection in C2D. Implications with regard to vaccination should be considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785571     DOI: 10.4049/jimmunol.177.1.722

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

2.  Adult survivors of invasive pneumococcal disease exhibit defective B cell function.

Authors:  Tom C Darton; James B Wing; Andrew Lees; Andrew W Heath; Robert C Read
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 3.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses.

Authors:  Andrew R Crowley; Simone I Richardson; Marina Tuyishime; Madeleine Jennewein; Meredith J Bailey; Jiwon Lee; Galit Alter; Guido Ferrari; Lynn Morris; Margaret E Ackerman
Journal:  Immunogenetics       Date:  2022-07-29       Impact factor: 3.330

5.  Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.

Authors:  Jose Yuste; Ashwin Sen; Lennart Truedsson; Göran Jönsson; Liang-Seah Tay; Catherine Hyams; Helen E Baxendale; Fiona Goldblatt; Marina Botto; Jeremy S Brown
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

6.  Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.

Authors:  Paolo G V Martini; Lynette C Cook; Scott Alderucci; Angela W Norton; Dianna M Lundberg; Susan M Fish; Knut Langsetmo; Göran Jönsson; Christian Lood; Birgitta Gullstrand; Kate J Zaleski; Nancy Savioli; Jason Lottherand; Charles Bedard; John Gill; Michael F Concino; Michael W Heartlein; Lennart Truedsson; Jan L Powell; Arthur O Tzianabos
Journal:  BMC Immunol       Date:  2010-08-20       Impact factor: 3.615

7.  Haplotypes of the bovine IgG2 heavy gamma chain in tick-resistant and tick-susceptible breeds of cattle.

Authors:  Wanessa Araújo Carvalho; Patricia Ianella; Frederico G C Arnoldi; Alexandre Rodrigues Caetano; Sandra Regina Maruyama; Beatriz Rossetti Ferreira; Luís Henrique Andreucci Conti; Marcia Ramos Monteiro da Silva; José Otavio F Paula; Antonio Augusto Mendes Maia; Isabel K Ferreira de Miranda Santos
Journal:  Immunogenetics       Date:  2011-02-08       Impact factor: 2.846

8.  Primary immunodeficiency in infection-prone children in southern Sweden: occurrence, clinical characteristics and immunological findings.

Authors:  Nicholas Brodszki; Göran Jönsson; Lillemor Skattum; Lennart Truedsson
Journal:  BMC Immunol       Date:  2014-08-14       Impact factor: 3.615

9.  Three-dimensional structure of the human myeloma IgG2.

Authors:  Sergey Ryazantsev; Vladimir Tischenko; Christopher Nguyen; Vyacheslav Abramov; Vladimir Zav'yalov
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.